Apolipoprotein E ε4 allele frequency in elderly depressed patients with and without cerebrovascular disease

Journal of the Neurological Sciences

Volumn 257, Issue 1-2, 2007, Pages 280-283

  Traykov, Latchezar ^a,b,c   Bayle, Anne Catherine ^a   Latour, Florence ^a   Lenoir, Hermine ^a   Seux, Marie Laure ^a   Hanon, Olivier ^a   Péquignot, Renaud ^a   Bert, Pierre ^a   Moulin, Florence ^a   Cantegreil, Inge ^a   Wenisch, Emilie ^a   Batouche, Fériel ^a   Mehrabian, Shima ^b   Rotrou, Jocelyne de ^a   Rigaud, Anne Sophie ^a  

^a Paris Descartes University   (France)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Alzheimer's disease; Apolipoprotein E; Cerebrovascular disease; Dementia; Late onset depression; Vascular depression

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; ALLELE; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ELDERLY CARE; EVIDENCE BASED PRACTICE; FEMALE; GENE FREQUENCY; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; AGING; ALZHEIMER DISEASE; EARLY DIAGNOSIS; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOTYPE; NUCLEOTIDE SEQUENCE; ONSET AGE; PREDICTION AND FORECASTING; PROGNOSIS; PSYCHOLOGICAL ASPECT;

AGE OF ONSET; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CEREBROVASCULAR DISORDERS; DEPRESSIVE DISORDER; DNA MUTATIONAL ANALYSIS; EARLY DIAGNOSIS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 34249800684     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.01.038     Document Type: Article

References (25)

1. Geerlings M.I., Schoevers R.A., Beekman A.T., Jonker C., Deeg D.J., Schmand B., et al. Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands. Br J Psychiatry 176 (2000) 568-575
2. Green R.C., Cupples L.A., Kurz A., Auerbach S., Sadovnick R., Go D., et al. Depression as a risk factor for Alzheimer disease: the MIRAGE study. Arch Neurol 60 (2003) 753-759
3. Henderson A.S., Korten A.E., Jacomb P.A., Mackinnon A.J., Jorm A.F., Christensen H., et al. The course of depression in the elderly: a longitudinal community-based study in Australia. Psychol Med 27 (1997) 119-129
4. Vinkers D.J., Gussekloo J., Stek M.L., Westendorp R.G.J., and van der Mast R.C. Temporal relation between depression and cognitive impairment in old age: prospective population based study. BMJ 329 (2004) 881-883
5. Burvill P.W., Hall W.D., Stampfer K.G., and Emmerson J.P. A comparison of early-onset and late-onset depressive illness in the elderly. Br J Psychiatr 155 (1989) 673-679
6. Alexopoulos G.S., Meyers B.S., Young R.C., Kakuma T., Silbersweig D., and Charlson M. Clinically defined vascular depression. Am J Psychiatry 154 (1997) 562-565
7. Krishnan K.R.R., Hays J.C., and Blazer D.G. MRI-defined vascular depression. Am J Psychiatry 154 (1997) 497-501
8. Cervilla J., Prince M., Joels S., Russ C., and Lovestone S. Genes related to vascular disease (APOE, VLDL-R, DCP-1) and other vascular factors in late-life depression. Am J Geriatr Psychiatry 12 (2004) 202-210
9. Roses A., Strittmatter W., Saunders A., Schmechel D., and Pericak-Vance M. Apolipoprotein E and Alzheimer's disease: state of the field after two years. In: Roses A., Weisgraber K., and Christen Y. (Eds). Apolipoprotein E and Alzheimer's Disease (1996), Springer, Berlin 1-10
10. Zubenko G.S., Henderson R., Stiffler J.S., Stabler S., Rosen J., and Kaplan B.B. Association of the APOE ε4 allele with clinical subtypes of late life depression. Biol Psychiatry 40 (1996) 1008-1016
11. Schmand B., Hooijer C., Jonker C., Lindeboom J., and Havekes L.M. Apolipoprotein E phenotype is not related to late-life depression in a population-based sample. Soc Psychiatry Psychiatr Epidemiol 33 (1998) 21-26
12. Krishnan K.R.R., Tupler L.A., Ritchie J.C., McDonald W.M., Knight D.L., Nemeroff C.B., et al. Apolipoprotein E-ε4 frequency in geriatric depression. Biol Psychiatry 40 (1996) 69-71
13. Hofman A., Ott A., Breteler M.M., Bots M.L., Slooter A.J., van Harskamp F., et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 349 (1997) 151-154
14. Dickson D.W., Roy N., Graff-Radford D., Perez-Tur J., Hardy J., Pearl G., et al. Apolipoprotein-E genotype influences amyloid deposition and limbic neurofibrillary degeneration, but not lewy body or vascular pathologies in postmortem brains. Neurology 52 Suppl 2 (1999) 562-563
15. Rigaud A.S., Latour F., Moulin F., Forette F., Traykov L., and Boller F. Apolipoprotein E epsilon4 allele and clinically defined vascular depression. Arch Gen Psychiatry 59 (2002) 290-291
16. Yesavage J., and Brink T.L. Development and validation of a Geriatric Depression Screening Scale: a preliminary report. J Psychiatr Res 17 (1983) 37-49
17. Folstein M.F., Folstein S.E., and Mc Hugh P.R. "Mini-mental test". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
18. De Rotrou J., Forette F., Hervy M.P., Tortrat D., Fermanian J., Boudou M.R., et al. The cognitive efficiency profile: description and validation in patients with Alzheimer disease. Int J Geriatr Psychiatry 6 (1991) 501-519
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
20. Mckhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer disease. Neurology 34 (1984) 939-944
21. Bailleul S., Couderc R., Landais V., Lefevre G., Raichvarg D., and Etienne J. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France). Hum Hered 43 (1993) 159-165
22. Steffens D.C., Norton M.C., Hart A.D., Skoog I., Corcoran C., Breitner J.C., and Cache County Study Group. Apolipoprotein E genotype and major depression in a community of older adults. The Cache County study. Psychol Med 33 (2003) 541-547
23. Mauricio M., O'Hara R., Yesavage J.A., Friedman L., Kraemer H.C., Van De Water M., et al. A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults. Am J Geriatr Psychiatry 8 (2000) 196-200
24. Rigaud A.S., Traykov L., Caputo L., Coste J., Latour F., Couderc R., et al. Association of the apolipoprotein E epsilon4 allele with late-onset depression. Neuroepidemiology 20 (2001) 268-272
25. Traykov L., Rigaud A.S., Baudic S., Smagghe A., Boller F., and Forette F. Apolipoprotein E varepsilon ε4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. J Neurol Sci 203-204 (2002) 177-181